The FDA has a trump card here, though - they don't have to decide anything on Ryoncil until the end of September - AFTER the interim ARDS results read out. If those results are stellar, they can simply find that SI and MSB have done enough to satisfy their concerns (even saying they will continue to monitor, take the ODAC's suggestions on this issue into account going forward for a Phase 4, etc.).
IMO @dplane you have nailed it here - it's all in the timing as they say and the way the cards have fallen with respect for 'timing' of Remestemcel-L approval date and COVID-19 ARDS interim assessment is somewhat remarkable - just sayin'
Good luck folks
- Forums
- ASX - By Stock
- MSB
- FDA ODAC Meeting Material discussion analysis
FDA ODAC Meeting Material discussion analysis, page-343
-
- There are more pages in this discussion • 149 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
99.0¢ |
Change
0.030(3.13%) |
Mkt cap ! $1.130B |
Open | High | Low | Value | Volume |
96.5¢ | $1.03 | 96.5¢ | $4.704M | 4.708M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 87395 | 98.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.00 | 274051 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 87395 | 0.985 |
3 | 116426 | 0.980 |
2 | 84419 | 0.975 |
3 | 54211 | 0.970 |
5 | 98141 | 0.965 |
Price($) | Vol. | No. |
---|---|---|
1.000 | 274051 | 2 |
1.005 | 49212 | 4 |
1.010 | 31212 | 2 |
1.015 | 72652 | 4 |
1.020 | 560 | 1 |
Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |